John Gordon on Nostr: GLP-1 for weight loss -- a lesson in the costs of drug development Several Novo ...
Published at
2024-02-13 00:36:47Event JSON
{
"id": "cf130f7af11789600f5ccffd7f080c395b3e6206f0568b68e17a5e8ec3fb4df2",
"pubkey": "b4d00963022b36dd89f15d59e5e7a3ad3c0683bb3b7e91295e05a33d6df19d52",
"created_at": 1707784607,
"kind": 1,
"tags": [
[
"t",
"jgshare"
],
[
"proxy",
"https://appdot.net/users/jgordon/statuses/111921372057807541",
"activitypub"
]
],
"content": "GLP-1 for weight loss -- a lesson in the costs of drug development\n\nhttps://www.science.org/content/blog-post/glp-1-demolition-derby\n\nSeveral Novo Nordisk competitors have flamed out ... a good illustration of why drug development is ferociously expensive (even before marketing and all the the rest).\n\n#jgshare",
"sig": "efb5d9f603dbb6363c8a0e53eb5f524fb9e5174d9d3ed948f06ac5ab25da715510942fd9a478c2276df12b14dd60ee1f20c9640c32c65480a8d413a007804701"
}